It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Medication Treatment Study for Patients with Depression

Clinical Trial Title: 
A study of an investigational medication as an add-on treatment for adults with depression.
Clinical Trial Protocol ID: 
17030611
Clinical Trial Investigator Name: 
John Zajecka, MD
Clinical Trial Protocol Description: 

This is a study to evaluate the safety and effectiveness of an investigational medication as an add-on treatment for adults with depression who are having an inadequate response to current antidepressant treatment. The study involves a screening period of 1-4 weeks, a treatment period of 6 weeks, and a follow-up period of 2 weeks. Participants will remain on the same antidepressant being taken at the time of study entry, with the investigational medication added on.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are between the ages 18-65 years old.
  • Meet criteria for depression.
  • Have been taking the same antidepressant for at least 6 weeks prior to study entry.
  • Are willing and able to use birth control (if you are a female of childbearing potential).

You will be excluded from the study if any of the following criteria apply to you:

  • Have certain other psychiatric or unstable medical illness, including bipolar disorder.
  • Test positive for drugs of abuse or alcohol at the time of screening.
  • Had your first episode of depression after age 60.
  • Have a history of cataract, glaucoma, eye trauma, or intraocular surgery (including laser surgery).
  • Are pregnant or breastfeeding.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Mental Health Disorders
Contact Phone: 
(312) 942-6597
Contact Name: 
Linda Skaggs